Cargando…
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review
The coronavirus disease 2019 (COVID-19) is until today a global health emergency. In an immense effort, effective drugs against COVID-19 are searched and intensive researches on possible repurposing of antiviral agents are performed. Since chloroquine (CQ) and hydroxychloroquine (HCQ) have shown in...
Autores principales: | Onori, Maria Elisabetta, Ricciardi Tenore, Claudio, Urbani, Andrea, Minucci, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901162/ https://www.ncbi.nlm.nih.gov/pubmed/33620659 http://dx.doi.org/10.1007/s11033-021-06234-y |
Ejemplares similares
-
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19
por: Laslett, Nicole, et al.
Publicado: (2021) -
Acquired Glucose-6-Phosphate Dehydrogenase Deficiency
por: Pes, Giovanni Mario, et al.
Publicado: (2022) -
Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
por: Minucci, Angelo, et al.
Publicado: (2021) -
Glucose-6 Phosphate Dehydrogenase Deficiency and Psychotic Illness
por: Singh, Vijender, et al.
Publicado: (2012) -
Glucose-6-Phosphate Dehydrogenase Deficiency in Nigerian Children
por: Williams, Olatundun, et al.
Publicado: (2013)